Abstract
Risperidone as an antipsychotic drug raises the risk of serious ventricular tachyarrhythmias and sudden cardiac death; co-administered with other potentially arrhythmogenic drugs the risk escalates. There are some electrocardiographic markers which may help predict such events. Case report We describe a 47-year-old woman with acute psychosis, who died suddenly subsequent to refractory ventricular arrhythmia, while on low dose risperidone combined with cotrimoxazole. Conclusion This case report suggests that use of risperidone even at a low dose and in an apparently healthy individual is associated with a heightened risk of lethal ventricular tachyarrhythmia. Therefore, clinicians should always be aware of such awkward effect. It is recommended to obtain baseline electrocardiogram in all patients and follow up electrocardiograms in selected patients when considering such therapy in order to avoid fatal outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
